MTOR and cancer: Given that both mTOR inhibitors and DNA methylation inhibitors are widely used in cancer therapy, we believe that determining the exact crosstalk between the mTOR pathway and DNA methylation can improve our ability to predict drug responses and develop better therapeutic regimens.